The Latin America, Middle East and Africa Aneurysm Clips Market should witness market growth of 11.3% CAGR during the forecast period (2022-2028).
Rapid advancement in information dissemination through the Internet has significantly helped the acceptance of aneurysm clips and disease treatments. Clinical management information, accessibility of aneurysm clips, pricing, faults in aneurysm clip materials biocompatibility, physician feedback, R&D, etc., are all available to the general public via open-source websites. This increases patient interest and promotes active physician-patient relationship management, leading to improved patient outcomes.
The active contribution to aneurysm clips market information by some of the major manufacturers streamlines the information distribution procedure and positively adds to the aneurysm clips market's consistent revenue growth. The interaction of hemodynamic stress with vascular insults, including arteriosclerosis and atherosclerosis, as well as genetic susceptibility, is thought to be the primary cause of aneurysm formation.
Depending on the size and location of the aneurysm, people with unruptured aneurysms may have localized neurological impairments, seizures, ocular symptoms, etc. Magnetic resonance imaging (MRI), computed tomography (CT), or digital subtraction angiography are typically used to pinpoint intracranial aneurysms.
In Brazil, medical devices are managed by the “ANVISA” (National Health Surveillance Agency) and by “INMETRO” (National Institute of Metrology Standardization and Industrial Quality), both publishing compulsory rules and voluntary product standards which medical device firms must follow to market their products. Life expectancy has increased in Africa than before. However, this region continues to encounter a burden of constant infectious disorders, and there is an increase in the occurrence of threat factors for chronic diseases. It is estimated that the population of elderly people in sub-Saharan Africa was at 43 million in 2010 and is predicted to reach 67 million by 2025 and 163 million by 2050.Due to the increase in life span, Africa will witness growth in the aneurysm clips adoption in the upcoming years, thereby supporting the regional market expansion. This supports the growth of the regional market.
The Brazil market dominated the LAMEA Aneurysm Clips Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,486.4 Thousands by 2028. The Argentina market is experiencing a CAGR of 11.9% during (2022-2028). Additionally, The UAE market would showcase a CAGR of 11% during (2022-2028).
Based on Material, the market is segmented into Titanium Aneurysm Clips, Polymer and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on Indication, the market is segmented into Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Stryker Corporation, Integra LifeSciences Holdings Corporation, Boston Scientific Corporation, B. Braun Melsungen AG (Aesculap, Inc.), Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences), KLS Martin Group, Adeor Medical AG, and Evonos GmbH & Co.KG.
Rapid advancement in information dissemination through the Internet has significantly helped the acceptance of aneurysm clips and disease treatments. Clinical management information, accessibility of aneurysm clips, pricing, faults in aneurysm clip materials biocompatibility, physician feedback, R&D, etc., are all available to the general public via open-source websites. This increases patient interest and promotes active physician-patient relationship management, leading to improved patient outcomes.
The active contribution to aneurysm clips market information by some of the major manufacturers streamlines the information distribution procedure and positively adds to the aneurysm clips market's consistent revenue growth. The interaction of hemodynamic stress with vascular insults, including arteriosclerosis and atherosclerosis, as well as genetic susceptibility, is thought to be the primary cause of aneurysm formation.
Depending on the size and location of the aneurysm, people with unruptured aneurysms may have localized neurological impairments, seizures, ocular symptoms, etc. Magnetic resonance imaging (MRI), computed tomography (CT), or digital subtraction angiography are typically used to pinpoint intracranial aneurysms.
In Brazil, medical devices are managed by the “ANVISA” (National Health Surveillance Agency) and by “INMETRO” (National Institute of Metrology Standardization and Industrial Quality), both publishing compulsory rules and voluntary product standards which medical device firms must follow to market their products. Life expectancy has increased in Africa than before. However, this region continues to encounter a burden of constant infectious disorders, and there is an increase in the occurrence of threat factors for chronic diseases. It is estimated that the population of elderly people in sub-Saharan Africa was at 43 million in 2010 and is predicted to reach 67 million by 2025 and 163 million by 2050.Due to the increase in life span, Africa will witness growth in the aneurysm clips adoption in the upcoming years, thereby supporting the regional market expansion. This supports the growth of the regional market.
The Brazil market dominated the LAMEA Aneurysm Clips Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,486.4 Thousands by 2028. The Argentina market is experiencing a CAGR of 11.9% during (2022-2028). Additionally, The UAE market would showcase a CAGR of 11% during (2022-2028).
Based on Material, the market is segmented into Titanium Aneurysm Clips, Polymer and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on Indication, the market is segmented into Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Stryker Corporation, Integra LifeSciences Holdings Corporation, Boston Scientific Corporation, B. Braun Melsungen AG (Aesculap, Inc.), Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences), KLS Martin Group, Adeor Medical AG, and Evonos GmbH & Co.KG.
Scope of the Study
By Material
- Titanium Aneurysm Clips
- Polymer
- Others
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Others
By Indication
- Stroke
- Cerebral Artery Stenosis
- Cerebral Aneurysm
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Abbott Laboratories
- Stryker Corporation
- Integra LifeSciences Holdings Corporation
- Boston Scientific Corporation
- B. Braun Melsungen AG (Aesculap, Inc.)
- Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
- KLS Martin Group
- Adeor Medical AG
- Evonos GmbH & Co.KG
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Aneurysm Clips Market, by Material
1.4.2 LAMEA Aneurysm Clips Market, by End-use
1.4.3 LAMEA Aneurysm Clips Market, by Indication
1.4.4 LAMEA Aneurysm Clips Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Aneurysm Clips Market by Material
3.1 LAMEA Titanium Aneurysm Clips Market by Country
3.2 LAMEA Polymer Market by Country
3.3 LAMEA Others Market by Country
Chapter 4. LAMEA Aneurysm Clips Market by End-use
4.1 LAMEA Hospitals Market by Country
4.2 LAMEA Ambulatory Surgical Centers Market by Country
4.3 LAMEA Others Market by Country
Chapter 5. LAMEA Aneurysm Clips Market by Indication
5.1 LAMEA Stroke Market by Country
5.2 LAMEA Cerebral Artery Stenosis Market by Country
5.3 LAMEA Cerebral Aneurysm Market by Country
5.4 LAMEA Others Market by Country
Chapter 6. LAMEA Aneurysm Clips Market by Country
6.1 Brazil Aneurysm Clips Market
6.1.1 Brazil Aneurysm Clips Market by Material
6.1.2 Brazil Aneurysm Clips Market by End-use
6.1.3 Brazil Aneurysm Clips Market by Indication
6.2 Argentina Aneurysm Clips Market
6.2.1 Argentina Aneurysm Clips Market by Material
6.2.2 Argentina Aneurysm Clips Market by End-use
6.2.3 Argentina Aneurysm Clips Market by Indication
6.3 UAE Aneurysm Clips Market
6.3.1 UAE Aneurysm Clips Market by Material
6.3.2 UAE Aneurysm Clips Market by End-use
6.3.3 UAE Aneurysm Clips Market by Indication
6.4 Saudi Arabia Aneurysm Clips Market
6.4.1 Saudi Arabia Aneurysm Clips Market by Material
6.4.2 Saudi Arabia Aneurysm Clips Market by End-use
6.4.3 Saudi Arabia Aneurysm Clips Market by Indication
6.5 South Africa Aneurysm Clips Market
6.5.1 South Africa Aneurysm Clips Market by Material
6.5.2 South Africa Aneurysm Clips Market by End-use
6.5.3 South Africa Aneurysm Clips Market by Indication
6.6 Nigeria Aneurysm Clips Market
6.6.1 Nigeria Aneurysm Clips Market by Material
6.6.2 Nigeria Aneurysm Clips Market by End-use
6.6.3 Nigeria Aneurysm Clips Market by Indication
6.7 Rest of LAMEA Aneurysm Clips Market
6.7.1 Rest of LAMEA Aneurysm Clips Market by Material
6.7.2 Rest of LAMEA Aneurysm Clips Market by End-use
6.7.3 Rest of LAMEA Aneurysm Clips Market by Indication
Chapter 7. Company Profiles
7.1 Medtronic PLC
7.1.1 Company overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.1.6 SWOT Analysis
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Stryker Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Integra LifeSciences Holdings Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental & Regional Analysis
7.4.4 Research & Development Expenses
7.5 Boston Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 B. Braun Melsungen AG (Aesculap, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 KLS Martin Group
7.8.1 Company Overview
7.9 Adeor Medical AG
7.9.1 Company Overview
7.10. Evonos GmbH & Co. KG
7.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Abbott Laboratories
- Stryker Corporation
- Integra LifeSciences Holdings Corporation
- Boston Scientific Corporation
- B. Braun Melsungen AG (Aesculap, Inc.)
- Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
- KLS Martin Group
- Adeor Medical AG
- Evonos GmbH & Co.KG
Methodology
LOADING...
